Matches in SemOpenAlex for { <https://semopenalex.org/work/W2937398468> ?p ?o ?g. }
Showing items 1 to 77 of
77
with 100 items per page.
- W2937398468 abstract "Introduction Autoimmune hepatitis (AIH) is a chronic, inflammatory liver condition which, if untreated, can Result in liver cirrhosis. Current BSG guidelines recommend corticosteroids and azathioprine as first line therapy, with the option of switching to mycophenolate if azathioprine is not tolerated. Tacrolimus has been identified as a potential third line treatment strategy. Our aim was to review the outcomes of patients with a diagnosis of AIH who required the addition of tacrolimus as a third line agent. Methods The tacrolimus database for the Regional Liver Unit, Royal Victoria Hospital was reviewed to identify all patients with AIH who had been treated with tacrolimus from Jan 2010 until August 2017. Records were cross referenced with the diagnostic coding department. Demographic details, indications for tacrolimus therapy, clinical and biochemical outcomes were recorded. Results 30 patients were identified (24 (80%) female, mean age 40.7 years, range 19–81 years). 27 of the 30 patients were initially treated with azathioprine of whom 21 (78%) discontinued treatment due to adverse effects including blood dyscrasias and 6 (22%) were switched to tacrolimus due treatment failure. Three of 30 patients were started on tacrolimus instead of azathioprine or mycophenolate. Two of these patients had previous episodes of pancytopenia at the time of commencing treatment for AIH and azathioprine/mycophenolate were excluded as a treatment option. One of the patients was commenced on prednisolone and tacrolimus without another steroid sparing agent trailed for other reasons. 26 (87%) of 30 patients remain on tacrolimus, of whom 11 (42%) had normalisation of transaminases and a further 12 (46%) had improvement of transaminases. Liver function tests in the 3 (11.5%) remaining patients were deranged but static. Of note all three had established cirrhosis at the time of AIH diagnosis. Of the four whose tacrolimus therapy was discontinued, two stopped due to side effects, 1 is deceased (not tacrolimus related) and one stopped due to commencing infliximab for IBD. Conclusions Tacrolimus is a safe and well tolerated treatment for AIH when first line therapy has failed. In the cohort observed, only 6% failed to tolerate tacrolimus and biochemical parameters were improved or normalised in 88% of patients who remained on tacrolimus therapy." @default.
- W2937398468 created "2019-04-25" @default.
- W2937398468 creator A5015010018 @default.
- W2937398468 creator A5023931454 @default.
- W2937398468 creator A5039521177 @default.
- W2937398468 creator A5043285130 @default.
- W2937398468 creator A5057499553 @default.
- W2937398468 creator A5070101272 @default.
- W2937398468 date "2018-06-01" @default.
- W2937398468 modified "2023-09-24" @default.
- W2937398468 title "PTH-084 The efficacy of tacrolimus as an alternative agent in the treatment of autoimmune hepatitis" @default.
- W2937398468 doi "https://doi.org/10.1136/gutjnl-2018-bsgabstracts.240" @default.
- W2937398468 hasPublicationYear "2018" @default.
- W2937398468 type Work @default.
- W2937398468 sameAs 2937398468 @default.
- W2937398468 citedByCount "0" @default.
- W2937398468 crossrefType "proceedings-article" @default.
- W2937398468 hasAuthorship W2937398468A5015010018 @default.
- W2937398468 hasAuthorship W2937398468A5023931454 @default.
- W2937398468 hasAuthorship W2937398468A5039521177 @default.
- W2937398468 hasAuthorship W2937398468A5043285130 @default.
- W2937398468 hasAuthorship W2937398468A5057499553 @default.
- W2937398468 hasAuthorship W2937398468A5070101272 @default.
- W2937398468 hasBestOaLocation W29373984681 @default.
- W2937398468 hasConcept C126322002 @default.
- W2937398468 hasConcept C141071460 @default.
- W2937398468 hasConcept C2776029263 @default.
- W2937398468 hasConcept C2776715498 @default.
- W2937398468 hasConcept C2776760755 @default.
- W2937398468 hasConcept C2777203481 @default.
- W2937398468 hasConcept C2779134260 @default.
- W2937398468 hasConcept C2779382419 @default.
- W2937398468 hasConcept C2780007613 @default.
- W2937398468 hasConcept C2909675724 @default.
- W2937398468 hasConcept C2911091166 @default.
- W2937398468 hasConcept C71924100 @default.
- W2937398468 hasConcept C90924648 @default.
- W2937398468 hasConceptScore W2937398468C126322002 @default.
- W2937398468 hasConceptScore W2937398468C141071460 @default.
- W2937398468 hasConceptScore W2937398468C2776029263 @default.
- W2937398468 hasConceptScore W2937398468C2776715498 @default.
- W2937398468 hasConceptScore W2937398468C2776760755 @default.
- W2937398468 hasConceptScore W2937398468C2777203481 @default.
- W2937398468 hasConceptScore W2937398468C2779134260 @default.
- W2937398468 hasConceptScore W2937398468C2779382419 @default.
- W2937398468 hasConceptScore W2937398468C2780007613 @default.
- W2937398468 hasConceptScore W2937398468C2909675724 @default.
- W2937398468 hasConceptScore W2937398468C2911091166 @default.
- W2937398468 hasConceptScore W2937398468C71924100 @default.
- W2937398468 hasConceptScore W2937398468C90924648 @default.
- W2937398468 hasLocation W29373984681 @default.
- W2937398468 hasOpenAccess W2937398468 @default.
- W2937398468 hasPrimaryLocation W29373984681 @default.
- W2937398468 hasRelatedWork W1502319745 @default.
- W2937398468 hasRelatedWork W2005169150 @default.
- W2937398468 hasRelatedWork W2048997301 @default.
- W2937398468 hasRelatedWork W2073392006 @default.
- W2937398468 hasRelatedWork W2105849586 @default.
- W2937398468 hasRelatedWork W2150198156 @default.
- W2937398468 hasRelatedWork W2415844199 @default.
- W2937398468 hasRelatedWork W2480433284 @default.
- W2937398468 hasRelatedWork W2556207576 @default.
- W2937398468 hasRelatedWork W2579004495 @default.
- W2937398468 hasRelatedWork W2605523210 @default.
- W2937398468 hasRelatedWork W2771711763 @default.
- W2937398468 hasRelatedWork W2783427082 @default.
- W2937398468 hasRelatedWork W2898625371 @default.
- W2937398468 hasRelatedWork W2978078855 @default.
- W2937398468 hasRelatedWork W2988855473 @default.
- W2937398468 hasRelatedWork W3031171793 @default.
- W2937398468 hasRelatedWork W3082109966 @default.
- W2937398468 hasRelatedWork W79672279 @default.
- W2937398468 hasRelatedWork W3143641191 @default.
- W2937398468 isParatext "false" @default.
- W2937398468 isRetracted "false" @default.
- W2937398468 magId "2937398468" @default.
- W2937398468 workType "article" @default.